The Department of Health and Human Services, National Institutes of Health, is seeking Roche Discovery Reagents through a Combined Synopsis/Solicitation notice. These reagents are used for lab experiments and maintaining continuity of results. They are ready-to-use research reagents designed for immunohistochemistry (IHC) and in situ hybridization (ISH) with the DISCOVERY ULTRA and DISCOVERY XT instruments. The purpose of this procurement is to support the research and research training programs of the National Institute of Allergy and Infectious Diseases (NIAID) in finding causes, improved methods, and prevention of immunologic and infectious diseases. The procurement includes specific items and quantities, such as DISCOVERY OmniMap anti-Rb HRP RUO (Qty - 6) and DISCOVERY Purple Kit RUO (Qty - 15), along with shipping and handling. The place of performance is in Hamilton, Montana, United States. The procurement will be awarded based on technical capability and price. Interested vendors must submit their quotes through the NIAID e-BidBoard System by August 2, 2024, at 4:00 PM EST. For more information, contact Rita Davis at rita.davis@nih.gov.